The proportion of patients receiving radiation therapy in Japan is less than half that in Europe and the United States. 1 The main reason for this is likely an insufficient number of radiation oncologists. 2 Additionally, we consider that the true reason may be insufficient promotion by radiologists in radiation therapy compared with clinicians in other fields. Completion of planned radiation therapy is an important factor in achieving a good outcome. However, sometimes radiation therapy is discontinued for various reasons. Thus, we analyzed the reasons for discontinuing radiation therapy.
All clinical procedures were performed in accordance with the ethical standards of the institutional and/or national research committee and the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from the patients.
Among 2141 patients who underwent radiation therapy between 2013 and 2016, 63 patients did not continue the planned radiation therapy. The reasons for discontinuation were deterioration of performance status (38 patients [60%]) and change of treatment option by the attending physician or patient (24 patients [40%]). In 18 of the 63 patients (28.5%) who discontinued radiation therapy, the initial intent was curative. In the remaining 45 patients (71.5%), the intent was palliative for pain control.
Death within or at 6 months after radiation therapy discontinuation occurred in 6 of 18 patients who discontinued curative radiation therapy (33.3%). Twelve of the patients who discontinued curative radiation therapy did not experience an early death. Among these 12, 9 patients (75%) discontinued radiation therapy due to adverse events and the other 3 experienced deterioration of performance status and unexpected complications. Four of the 9 patients underwent chemoradiation therapy for lung cancer, and all 4 discontinued radiation therapy due to prolonged myelosuppression caused by chemotherapy.
Psychological support is important before and during the period of radiation therapy administration. Three of 9 patients with head and neck cancer discontinued radiation therapy due to pain induced by stomatitis and dermatitis as well as fear and anxiety of possibly more severe adverse reactions. In these cases, information for consent given prior to the initiation of radiation therapy by the radiation oncologist may have been inadequate for both the patient and members of care team, including otolaryngologist or dermatologist. In addition, cooperation among the team members may have been less than optimal.
We agree with the comments by Dr. Stanislav Lazarev et al with regard to the premature discontinuation of curative radiation therapy. For successful implementation of cancer treatment, radiation oncologists, attending physicians of various disciplines, and other health care providers must work as a team to understand the patient's general condition. The team members should share information about adverse events and other relevant issues.
